Restart Life Sciences Details Next-Generation Product Pipeline and Segment Expansion for Holy Crap

About this update from Restart Life Sciences Corp.

Vancouver, British Columbia--(Newsfile Corp. - July 8, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to provide an update on its forward-looking product development and segment expansion roadmap for its wholly owned subsidiary, Holy Crap Foods Inc. Following the Company's recent disclosure of its preliminary June 2026 financial growth highlights, management is working to build upon this operational trajectory by systematically diversifying the Holy Crap brand into specialized consumer demographics. Following the successful completion of its market research and conceptual design phases, the Company has advanced into formulation testing for a new product line targeting the premium youth breakfast sector. Management has identified a high-growth opportunity to capture market share within this demographic by introducing a family-centric packaging strategy. This expansion is engineered to complement Holy Crap's core product portfolio while securing incremental, multi-placement shelf space across both conventional and natural grocery retail channels. The expansion into the youth category aligns with shifting consumer behavior within the broader breakfast sector: Concurrently, the Company's formulation team is developing a senior-specific product(s) to capture a mature demographic previously unaddressed by the brand's existing product architecture. The proposed formulation will focus heavily on targeted digestive health, ingredient bioavailability, and metabolic support tailored to the aging population. The addressable market parameters for senior-focused functional breakfast nutrition indicate substantial commercial scope:

View stock analysis, news, and events for Restart Life Sciences Corp.